Workowski KA, Bolan GA; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1-137.
Martin DH, Bowie WR. Urethritis in males. In: Holmes KK, Sparling PF, Mardh P, et al., eds. Sexually transmitted diseases. 3rd ed. New York, NY: McGraw-Hill; 1999:833-845.
Centers for Disease Control and Prevention. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae - 2014. MMWR Recomm Rep. 2014;63:1-19.
Horner P, Blee K, O'Mahony C, et al; Clinical Effectiveness Group of the British Association for Sexual Health and HIV. 2015 UK national guideline on the management of non-gonococcal urethritis. Int J STD AIDS. 2015 May 22. [Epub ahead of print]
The American College of Obstetricians and Gynecologists. Committee opinion no. 506: expedited partner therapy in the management of gonorrhea and chlamydia by obstetrician-gynecologists. Obstet Gynecol. 2011;118:761-766.
Centers for Disease Control and Prevention. Expedited partner therapy in the management of sexually transmitted diseases. 2006. http://www.cdc.gov/ (last accessed 10 October 2016).
1. Workowski KA, Bolan GA; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1-137.
2. Martin DH, Bowie WR. Urethritis in males. In: Holmes KK, Sparling PF, Mardh P, et al., eds. Sexually transmitted diseases. 3rd ed. New York, NY: McGraw-Hill; 1999:833-845.
3. McCormack WM, Rein MF. Urethritis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 6th ed. Pennsylvania: Churchill Livingstone; 2005:1347-1357.
4. Holmes KK, Stamm WE. Lower genital tract infection syndromes in women. In: Holmes KK, Sparling PF, Mardh P, et al., eds. Sexually Transmitted Diseases, 3rd ed. New York, NY: McGraw-Hill; 1999:761-781.
5. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2013. http://www.cdc.gov (last accessed 10 October 2016).
6. Health Protection Agency. Testing times: HIV and other sexually transmitted infections in the United Kingdom: 2007. http://webarchive.nationalarchives.gov.uk (last accessed 10 October 2016).
7. GRASP Steering Group. GRASP: the gonococcal resistance to antimicrobials surveillance programme annual report 2007. 2008. http://www.hpa.org.uk/ (last accessed 10 October 2016).
8. Creighton S, Tenant-Flowers M, Taylor CB, et al. Co-infection with gonorrhoea and chlamydia: how much is there and what does it mean? Int J STD AIDS. 2003;14:109-113.
9. Totten PA, Schwartz MA, Sjostrom KE, et al. Association of Mycoplasma genitalium with nongonococcal urethritis in heterosexual men. J Infect Dis. 2001;183:269-276.
10. Yokoi S, Maeda S, Kubota Y, et al. The role of Mycoplasma genitalium and Ureaplasma urealyticum biovar 2 in postgonococcal urethritis. Clin Infect Dis. 2007;45:866-871.
11. Gambini D, Decleva I, Lupica L, et al. Mycoplasma genitalium in males with nongonococcal urethritis: prevalence and clinical efficacy of eradication. Sex Transm Dis. 2000;27:226-229.
12. Bradshaw CS, Tabrizi SN, Read TR, et al. Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure. J Infect Dis. 2006;193:336-345.
13. Schlicht MJ, Lovrich SD, Sartin JS, et al. High prevalence of genital mycoplasmas among sexually active young adults with urethritis or cervicitis symptoms in La Crosse, Wisconsin. J Clin Microbiol. 2004;42:4636-4640.
14. Mena L, Wang X, Mroczkowski TF, et al. Mycoplasma genitalium infections in asymptomatic men and men with urethritis attending a sexually transmitted diseases clinic in New Orleans. Clin Infect Dis. 2002;35:1167-1173.
15. Horner P, Thomas B, Gilroy CB, et al. Role of Mycoplasma genitalium and Ureaplasma urealyticum in acute and chronic nongonococcal urethritis. Clin Infect Dis. 2001;32:995-1003.
16. Holmes KK, Hansfield HH, Wang SP, et al. Etiology of nongonococcal urethritis. N Engl J Med. 1975;292:1199-1205.
17. Taylor SN. Mycoplasma genitalium. Curr Infect Dis Rep. 2005;7:453-457.
18. Martin DH. Nongonococcal urethritis: new views through the prism of modern molecular biology. Curr Infect Dis Rep. 2008;10:128-132.
19. Schwebke JR, Hook EW 3rd. High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: Implications for screening and urethritis management. J Infect Dis. 2003;188:465-468.
20. Nacey JN, Tulloch AG, Ferguson AF. Catheter-induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. Br J Urol. 1985;57:325-328.
21. Lemon SM, Sparling PF. Pathogenesis of sexually transmitted viral and bacterial infections. In: Holmes KK, Sparling PF, Mardh P, et al., eds. Sexually transmitted diseases. 3rd ed. New York, NY: McGraw-Hill; 1999:205-212.
22. Johnson AP. Pathogenesis and immunology of chlamydial infections of the genital tract. Rev Infect Dis. 1985;7:741-745.
23. Horner P, Thomas B, Gilroy C, et al. Antibodies to Chlamydia trachomatis heat-shock protein 60 kDa and detection of Mycoplasma genitalium and Ureaplasma urealyticum are associated independently with chronic nongonococcal urethritis. Sex Transm Dis. 2003;30:129-133.
24. Chacko MR, Lovchik JC. Chlamydia trachomatis infection in sexually active adolescents: prevalence and risk factors. Pediatrics. 1984;73:836-840.
25. Smith GL, Greenup R, Takafuji E. Circumcision as a risk factor for urethritis in racial groups. Am J Public Health. 1987;77:452-454.
26. Van Howe RS. Genital ulcerative disease and sexually transmitted urethritis and circumcision: a meta-analysis. Int J STD AIDS. 2007;18:799-809.
27. Rothenberg R, Judson FN. The clinical diagnosis of urethral discharge. Sex Transm Dis. 1983;10:24-28.
28. Centers for Disease Control and Prevention. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae - 2014. MMWR Recomm Rep. 2014;63:1-19.
29. Bignell C, Unemo M; European STI Guidelines Editorial Board. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2013;24:85-92.
30. Association of Public Health Laboratories. Laboratory diagnostic testing for Chlamydia trachomatis and Neisseria gonorrhoeae: expert consultation meeting summary report. January 2009. http://www.aphl.org/ (last accessed 10 October 2016).
31. US Preventive Services Task Force. Screening for gonorrhea: recommendation statement. Ann Fam Med. 2005;3:263-267.
32. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev. 1997;10:160-184.
33. Yoshida T, Maeda S, Deguchi T, et al. Rapid detection of Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum, and Ureaplasma urealyticum organisms in genitourinary samples by PCR-microtiter plate hybridization assay. J Clin Microbiol. 2003;41:1850-1855.
34. Parker CT, Thomas D. Reiter's syndrome and reactive arthritis. J Am Osteopath Assoc. 2000;100:101-104.
35. National Health Service. National Chlamydia Screening Programme, England. 3rd Ed September 2006.
36. US Preventive Services Task Force. Screening for chlamydial infection: recommendation statement. Ann Intern Med. 2007;147:128-134.
37. International Union against Sexually Transmitted Infections. 2016 European Guideline on the management of non-gonococcal urethritis. 2016. http://www.iusti.org/ (last accessed 10 October 2016).
38. Horner P, Blee K, O'Mahony C, et al; Clinical Effectiveness Group of the British Association for Sexual Health and HIV. 2015 UK national guideline on the management of non-gonococcal urethritis. Int J STD AIDS. 2015 May 22. [Epub ahead of print]
39. Hogben M. Partner notification for sexually transmitted diseases. Clin Infect Dis. 2007;44:S160-S174.
40. Golden MR, Whittington WL, Handsfield HH, et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med. 2005;352:676-685.
41. The American College of Obstetricians and Gynecologists. Committee opinion no. 506: expedited partner therapy in the management of gonorrhea and chlamydia by obstetrician-gynecologists. Obstet Gynecol. 2011;118:761-766.
42. Seña AC, Lensing S, Rompalo A, et al. Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: predictors and persistence after therapy. J Infect Dis. 2012;206:357-365.
43. Manhart LE, Gillespie CW, Lowens MS, et al. Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial. Clin Infect Dis. 2013;56:934-942.
44. Bradshaw CS, Chen MY, Fairley CK. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS One. 2008;3:e3618.
45. Jensen JS, Bradshaw CS, Tabrizi SN, et al. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with inducible macrolide resistance. Clin Infect Dis. 2008;47:1546-1553.
46. Maeda S, Yasuda M, Ito S, et al. Azithromycin treatment for nongonococcal urethritis negative for chlamydia trachomatis, mycoplasma genitalium, mycoplasma hominis, ureaplasma parvum, and ureaplasma urealyticum. Int J Urol. 2009;16:215-216.
47. Bradshaw CS, Jensen JS, Tabrizi SN, et al. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg Infect Dis. 2006;12:1149-1152.
48. Mena LA, Mroczkowski TF, Nsuami M, et al. A randomized comparison of azithromycin and doxycycline for the treatment of mycoplasma genitalium-positive urethritis in men. Clin Infect Dis. 2009;48:1649-1654.
49. Schwebke JR, Rompalo A, Taylor S, et al. Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial. Clin Infect Dis. 2011;52:163-170.
50. Centers for Disease Control and Prevention. Expedited partner therapy in the management of sexually transmitted diseases. 2006. http://www.cdc.gov/ (last accessed 10 October 2016).
51. Igietseme J, Eko F, He Q, et al. Delivery of chlamydia vaccines. Expert Opin Drug Deliv. 2005;2:549-562.
52. Centers for Disease Control and Prevention. Trends in sexually transmitted diseases in the United States: 2009 national data for gonorrhea, chlamydia and syphilis. 2010. http://www.cdc.gov/ (last accessed 10 October 2016).
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台